Keywords: sanofi-synthelabo, sales, rise, france, says, rose, billioneuros
Sanofi-Synthelabo sales rise 10.3%
Article | 29 January 2001
France's Sanofi-Synthelabo says sales in 2000 rose 10.3% to 5.96 billioneuros ($5.59 billion) on a consolidated basis, while fourth-quarter turnover climbed 7.5% to 1.62 billion euros.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
